These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 9254534)

  • 1. [The prevention of insulin-dependent diabetes mellitus].
    Loureiro MM; Duarte R; Boavida JM; Lisboa PE
    Acta Med Port; 1996; 9(10-12):353-60. PubMed ID: 9254534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New data concerning the etiology of insulin-dependent diabetes].
    Deschamps I; Khalil I; Beressi JP; Hors J; Robert JJ
    Ann Pediatr (Paris); 1991 Apr; 38(4):205-10. PubMed ID: 2069353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoimmunity and insulin-dependent diabetes mellitus. Experimental data and therapeutic prospects].
    Thivolet C; Khallouf E
    Pediatrie; 1989; 44(4):247-57. PubMed ID: 2677968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of genetic and immunological factors in the etiology of insulin-dependent diabetes].
    Deschamps I; Hors J; Robert JJ
    Schweiz Med Wochenschr; 1990 Jan; 120(3):46-53. PubMed ID: 2405478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can insulin therapy delay or prevent insulin-dependent diabetes mellitus?
    Kakka R; Koda-Kimble MA
    Pharmacotherapy; 1997; 17(1):38-44. PubMed ID: 9017764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is insulin-dependent diabetes mellitus a preventable disease?
    Maclaren NK; Riley WJ; Winter WE; Silverstein JH
    Clin Invest Med; 1987 Sep; 10(5):444-9. PubMed ID: 3315366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-phase insulin response in young healthy children at genetic and immunological risk for Type I diabetes.
    Keskinen P; Korhonen S; Kupila A; Veijola R; Erkkilä S; Savolainen H; Arvilommi P; Simell T; Ilonen J; Knip M; Simell O
    Diabetologia; 2002 Dec; 45(12):1639-48. PubMed ID: 12488953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
    Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nicotinamide and prevention of insulin-dependent diabetes mellitus. Rationale, effects, toxicology and clinical experiences. ENDIT Group].
    Reimers JI; Andersen HU; Pociot F
    Ugeskr Laeger; 1994 Jan; 156(4):461-5. PubMed ID: 8140661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological aspects of diabetes.
    Cheţa D
    Recenti Prog Med; 1990 Feb; 81(2):72-8. PubMed ID: 2195611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?
    Schatz D; Cuthbertson D; Atkinson M; Salzler MC; Winter W; Muir A; Silverstein J; Cook R; Maclaren N; She JX; Greenbaum C; Krischer J
    Pediatr Diabetes; 2004 Jun; 5(2):72-9. PubMed ID: 15189492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Principles of immunotherapy in insulin-dependent diabetes mellitus].
    Bretzel RG
    Wien Klin Wochenschr; 1988 Jun; 100(13):435-42. PubMed ID: 3043913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signs of beta-cell autoimmunity and HLA-defined diabetes susceptibility in the Finnish population: the sib cohort from the Type 1 Diabetes Prediction and Prevention Study.
    Kukko M; Kimpimäki T; Kupila A; Korhonen S; Kulmala P; Savola K; Simell T; Keskinen P; Ilonen J; Simell O; Knip M
    Diabetologia; 2003 Jan; 46(1):65-70. PubMed ID: 12637984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is prevention of diabetes mellitus possible?].
    Lehmann R; Spinas GA
    Ther Umsch; 1994 Oct; 51(10):693-700. PubMed ID: 7839327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenesis, prediction, and prevention of insulin-dependent diabetes mellitus.
    Muir A; Schatz DA; Maclaren NK
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):199-219. PubMed ID: 1612064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies in type 1 diabetes.
    Taplin CE; Barker JM
    Autoimmunity; 2008 Feb; 41(1):11-8. PubMed ID: 18176860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of type 1a diabetes mellitus*.
    Wilson DM; Buckingham B
    Pediatr Diabetes; 2001 Mar; 2(1):17-24. PubMed ID: 15016206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can we predict and/or prevent type I diabetes?
    Sandler M
    S Afr Med J; 1990 Oct; 78(8):462-7. PubMed ID: 2218782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.